Last reviewed · How we verify

NCT03749811: PURFT

Pupillometry-guided Remifentanil Infusion Versus Conventional Administration in Children

Status unknown NA Last updated 29 March 2019
What this trial tests

NA trial testing Pupillometry in Opioid Use in 60 participants. Status unknown.

Timeline
4 December 2018
Primary endpoint
18 November 2020
18 November 2021

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingtriple
Primary purposetreatment
Enrollment60
Start date4 December 2018
Primary completion18 November 2020
Estimated completion18 November 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Adults 3 to 12, any sex, with Opioid Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our study aims to compare the total intravenous dose of remifentanil per anesthesia hour and body weight in two groups of pediatric surgical patients - an interventional group with remifentanil infusion under pupillometry monitoring, and control group without pupillometry - to figure out whether pupillometry monitoring may reduce remifentanil consumption during anesthesia while providing sufficient analgesia for surgical noxious stimuli.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pupillometry

Trials testing the same drug.

Other recruiting trials for Opioid Use

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03749811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing